Last updated on September 11th, 2021 at 02:56 pm
A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report.
MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damage that results in neurological problems.
However, the cause is unclear. Studies in a mouse model of MS – called experimental autoimmune encephalomyelitis (EAE) – have shown that immune T-cells, which secrete an immune molecule called IL-17, damage the myelin sheath surrounding nerves in the central nervous system (CNS).
Drugs that block IL-17 have shown promise in early clinical trials for treatment of relapsing-remitting MS. The drugs have already been licensed for treating psoriasis.
Links between the United Arab Emirates and Nigeria have reached an important milestone with the resumption of daily Emirates Airlines…
As part of His Highness' working visit to Egypt, His Highness Sheikh Mohamed bin Zayed Al Nahyan and His Excellency…
United Arab Emirates will invest $23 billion over five years in next-generation low-carbon energy, such as hydrogen and ammonia, to…
After making a memorable appearance at the WellChild Awards in the United Kingdom, Prince Harry landed at his next destination…
Tanzanian music sensation Diamond Platnumz, best known for her hit ‘Komasava’, is set to take on Nigeria's finest artists at…
Oliver Mawuse Barker Vormawor, the organiser of the ‘StopGalamseyNow’ demonstration, and 11 other demonstrators have been remanded in custody until…
This website uses cookies.